Regeneron Pharmaceuticals, Inc. (REGN)
788.31
+8.64
(+1.11%)
USD |
NASDAQ |
Feb 23, 13:36
Regeneron Pharmaceuticals Market Cap : 83.34B for Feb. 23, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 205.27B |
| Gilead Sciences, Inc. | 185.99B |
| Johnson & Johnson | 592.04B |
| Eli Lilly & Co. | 992.72B |
| Merck & Co., Inc. | 306.55B |
Market Cap Related Metrics
| PE Ratio | 18.97 |
| PS Ratio | 5.970 |
| PEG Ratio | 2.216 |
| Price to Book Value | 2.666 |
| Price to Free Cash Flow | 22.74 |
| Price | 788.31 |
| Earnings Yield | 5.27% |
| PEGY Ratio | 2.103 |
| Operating PE Ratio | 23.13 |
| Normalized PE Ratio | 19.37 |